Healthcare information provider Wolters Kluwer Health has updated the Lippincott Procedures online software with a set of medical-surgical nursing procedures that underwent extensive review by the Academy of Medical-Surgical Nurses (AMSN), which claims to be the largest nursing organisation dedicated to the medical-surgical specialty. One-quarter of the 395 AMSN-endorsed procedures are included in the October Lippincott Procedures update with the remainder to be released quarterly through July 2015.
Regularly updated with the latest evidence, Lippincott Procedures is one of the leading online clinical decision-support solutions used by nurses and other clinicians at the bedside.
All 395 medical-surgical procedures are being reviewed, developed and/or modified by a select team of experts from the AMSN membership of more than 11,000 nurses. The first set of approximately 96 new and updated procedures, including 'Safe Medication Administration Practices' and 'Indwelling Urinary Catheter (Foley) Care and Management,' is available to subscription customers in the product's October quarterly software update. All of the AMSN-reviewed procedures are endorsed to meet current, evidence-based standards of exemplary quality-of-care as defined by AMSN.
Lippincott Procedures is one of the most widely deployed, web-based nursing applications for evidence-based practice information used in hospitals and other healthcare institutions. It gives clinicians accurate, step-by-step guidance for more than 1,600 evidence-based procedures. Video clips and high-quality visuals that aid in understanding accompany most of the procedures. Skills checklists and competency tests for each procedure are provided to help facilities verify staff competence. Each procedure undergoes a thorough annual review process to ensure it includes the most up-to-date clinical information.
Lippincott Procedures, part of the Lippincott Solutions product suite, is available as a group subscription to hospitals and other healthcare facilities. The product is accessible from any Internet-enabled device including PCs and mobile devices including iPad and Android tablets as well as an iPad app.
